期刊文献+

嗅神经母细胞瘤鼻内镜治疗探讨 被引量:2

Endoscopic Sinus Surgery of Olfactory Neuroblastoma
下载PDF
导出
摘要 目的探讨经鼻内镜手术治疗嗅神经母细胞瘤的可行性及疗效。方法回顾性分析我院2003年1月一2007年12月间收治的9例嗅神经母细胞瘤患者临床资料,按Kadish改良分期为A期1例,B期5例,C期2例,D期1例,均行鼻内镜下肿瘤切除术,术后接受放疗和化疗。结果全组病例术后无颅内感染、脑脊液鼻漏、视力受损等并发症。9例均获随访,平均随访时间79(56—112)个月。共4例患者复发:1例B期患者首次治疗后2年内出现鼻腔鼻窦复发,再次行鼻内镜肿瘤切除术、颈淋巴清扫术,术后化疗和放疗,1年后死于颅内复发;1例C期患者于1年后死于颅内复发,另1例c期在术后4年死于颅内复发和感染;D期的1例患者2年后死于肺部和骨复发。本组病例3年生存率为66.7%(6/9),5年生存率为55.6%(5/9)。结论鼻内镜下肿瘤切除术对临床A、B期嗅神经母细胞瘤是一种有效治疗方法,对晚期病人应行颅面或颅鼻径路鼻内镜辅助下肿瘤切除术。 Objective To explore the feasibility and therapeutic efficacy of transnasal endoscopic resec- tion for olfactory neuroblastoma. Methods A total of 9 patients with olfactory neuroblastoma admitted from January 2003 to December 2007 were analyzed retrospectively, including 1 cases of stage A, 5 cases of stage B, 2 cases of stage C and 1 case of stage D according to the modified Kadish clinical staging. All cases were per- formed tumor resection under nasal endoscope and following radiotherapy and chemotherapy. Results There was no complication such as intracranial infection, cerebrospinal fluid rhinorrhea and visual impairment. All 9 cases were followed up for 56 to 112 months with an average of 79 months. Four cases were found local rescur- rence: One case with stage B recurred in nasal cavity and paranasal sinuses 2 years after the operation and re- ceived reoperation, chemo- and radio-therapy, then died of intracalvarium recurrence 1 year after the reopera- tion; Two cases with stage C was died of intracalvarium recurrence 1 year after the operation and intracalvarium relapse and infection 4 years after the operation respectively; One case with stage D was died of recurrence in lung and bone 2 years after the operation. The 3-year survival rate was 66.7% (6/9) and the 5-year survival rate was 55.6% (5/9). Conclusion The tumorectomy via endoscopic sinus surgery is an effective method for the olfactory neuroblastoma patients with stage A and B, however the tumorectomy via transnasal endoscope approach combined with craniotomy should be recommended for the advanced patients with stage C and D.
出处 《中国现代手术学杂志》 2014年第3期224-226,共3页 Chinese Journal of Modern Operative Surgery
关键词 成感觉神经细胞瘤 嗅觉 内窥镜检查 esthesioneuroblastoma, olfactory endoscopy, nasal
  • 相关文献

参考文献9

  • 1Bak M, Wein RO. Esthesioneuroblastoma: a contemporary review of diagnosis and management[J].Hematol Oncol Clin North Am, 2012, 26(6) :1185-1207. doi: 10. 1016/j. hoc. 2012.08. 005.
  • 2Papacharalampous GX, Vlastarakos PV, Chrysovergis A, et al. Olfactory neuroblastoma (esthesioneuroblastoma) : towards mini- mally invasive surgery and multi-modality treatment strategies-an updated critical review of the current literature [ J ]. J BUON, 2013, 18(3) :557-563.
  • 3龚巧英,吴新生.嗅神经母细胞瘤36例临床分析[J].实用癌症杂志,2010,25(1):68-70. 被引量:7
  • 4Tsuchiya D, Kayama T, Kuchiki H, et al. A case of olfactory neu- roblastoma with intracranial extension and distant metastasis [ J ]. No To Shinkei, 2000, 52(9) :811-816.
  • 5赵素萍,肖健云,刘志雄.改良经颅径路行前颅底肿瘤切除[J].中国耳鼻咽喉颅底外科杂志,2001,7(4):201-203. 被引量:10
  • 6贾弘光,倪鑫,黄志刚,房居高,王琪.嗅神经母细胞瘤的鼻内镜治疗[J].中国耳鼻咽喉头颈外科,2009,16(5):247-250. 被引量:7
  • 7Komotar R J, Starke RM, Raper DiVI, et al. Endoscopic endonasal compared with anterior craniofacial and combined cranionasal re- section of esthesioneurob [J]. World Neurosurg, 2013,80 (1-2) : 148-159. doi: 10. 1016/j. wneu. 2012.12. 003.
  • 8Song CM, Won TB, Lee CH, et al. Treatment modalities and out- comes of olfactory neuroblastoma [ J ]. Laryngoscope, 2012, 122 ( 11 ) :2389-2395. doi : 10. 1002/lary. 23641.
  • 9Gallia GL, Reh DD, Lane AP, et al. Endoscopic resection of es- thesioneuroblastoma[ J]. J Clin Neuresci, 2012, 19 ( 11 ) : 1478- 1482. doi : 10. 1016/j. joen. 2012.03. 011.

二级参考文献21

  • 1韩德民.鼻内镜下颅底手术[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):321-323. 被引量:11
  • 2王琪,韩德民.鼻内镜颅底外科[J].中国医学文摘(耳鼻咽喉科学),2007,22(4):199-201. 被引量:7
  • 3Kadish S, Goodman M, Wang CC, et al. Olfactory neuroblastoma a clinical analysis of 17 cases. Cancer, 1976, 37: 1571-1576.
  • 4Berger L, Luc R, Richard J. Lesthesioneuroepitheliome olfactif. BullAssoc Fretude Cancer, 1924, 13: 410-421.
  • 5Loy AH, Reibel JF, Read PW. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg, 2006, 132: 134-138.
  • 6Walch C, Stammberger H, Unger F, et al. A new therapy concept in esthesioneuroblastoma. Laryngorhinootologie, 2000, 79: 743-748.
  • 7Unger F, Haselsberger K, Walch C, et al, Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma) . Acta Neurochir (Wien) , 2005, 147: 595-601.
  • 8Suriano M, Vincentiis MD, Colli A, et al. Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg, 2007. 136: 104-107.
  • 9Goldweig H G, Sundaresan N. Chemotherapy of recurrent esthesioneuroblastom a case report and review of the literature[J]. Am J Clin Oncol, 1990,13 : 139.
  • 10Kadish S, Goodman M, Wang CC, et al. Olfactory neuroblastoma: a clinical analysis of 17 cases [J]. Cancer, 1976,37 : 1571.

共引文献19

同被引文献18

  • 1张秋航.鼻内镜颅底外科的适应证[J].中国医学文摘(耳鼻咽喉科学),2006,21(2):76-78. 被引量:7
  • 2NICOLAI P, BATTAGI.IA P, BIGNAMI M, et al. Endoscopic surgery for malignant tumors of the si- nonasal tract and adjacent skull base: a 10-year expe- rience[J]. Am J Rhinol,2008,22:308-316.
  • 3HANNA E, DEMONTE F, IBRAHIM S, et al. En- doscopic resection of sinonasal cancers with and with- out craniotomy: oncologic results[J]. Arch Otolaryn- gol Head Neck Surg,2009,135:1219-1224.
  • 4KOMOTAR R J, STARKER M, RAPER D M, et al. Endoscopic endonasal compared with anterior cranio- facial and combined cranionasaI resection of esthesio- neuroblastomas[J]. World Neurosurgery, 2013,80: 148-159.
  • 5VILLARET A B ,YAKIREVITCH A, BIZZONI A, et al. Endoscopic transnasal craniectomy in the man- agement of selected sinonasal malignancies[J]. Am J Rhinol Allergy, 2010,24 : 60- 65.
  • 6LUONG A, CITARDI M J , BATRA P S. Manage- ment of sinonasal malignant neoplasms: defining the role of endoscopy[J]. Am J Rhinol Allergy, 2010,24 : 50-155.
  • 7Duxbury MS, Ito H, Benoit E, et al. RNA interference demon- strates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance [J]. Clin Cancer Res, 2005, 11:3433-3438.
  • 8Takanami I. Increased expression of intelvin-linked kinase is as- sociated with shorter survival in non-small cell lung cancer[ J ]. BMC Cancer, 2005, 5:1-1.
  • 9Ito R, Oue N,Zhu X, et al. Expression of integrin linked kinase is closely correlated with invasion and metastasis gastric carcino- ma[ J]. Virchows Arch, 2003, 442:118-123.
  • 10Park CC ,Zhang H,Pallavicini M,et al. Beta1 integrin inhibito- ry antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo[ J ]. Cancer Res, 2006, 66 : 1526-1535.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部